Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NewCardio appoints Vincent Renz president

This article was originally published in Clinica

Executive Summary

Cardiac diagnostics and services firm NewCardio has made Vincent Renz its president. Mr Renz has over 26 years of experience in the information technology industry, and was previously chief operating officer of ClinPhone, a clinical technology organisation. Before that he was executive vice-president and chief technology officer for eResearch Technology. Santa Clara, California-based NewCardio says the validation of its lead product, QTinno, is “essentially complete”. The device is an ECG platform technology to improve the diagnostic accuracy of the standard 12-lead ECG.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT043435

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel